Clin2
NCT07448389Likely a fitNot yet recruiting

Study of leprosy cases in Costa Rica

LeprosyHansen's DiseaseLeprosy--PatientsLepromatous LeprosyLeprosy, MultibacillaryLeprosy Neuropathy

Part of Infections clinical trials.

This study looks at people with Hansen's disease (leprosy) in Costa Rica to understand how it affects them and how it's treated. By joining, you help researchers learn more about this condition to improve care for others.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
130 people
Ages
Any age
Study type
Observational

Who can take part

  • You have a confirmed diagnosis of Hansen's disease (leprosy).
  • Your diagnosis was made between January 2018 and December 2025.
  • You were diagnosed or treated at a public health facility in Costa Rica.
  • Your case has been reported to Costa Rica's national health surveillance system.
  • Your medical records are available in the digital system.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06222372Recruiting
New approaches for leprosy diagnosis and treatment

This study looks at new ways to diagnose and treat leprosy. It includes patients with a more serious form of leprosy and the people who live closely with them, to help stop the spread of the disease.

Nilphamari
NCT06819449Recruiting
Gene Study for Leprosy Prognosis

This study looks at whether a specific gene (Rab 32) affects how leprosy progresses. It may help doctors better predict outcomes for people with leprosy.

Qina
NCT07248462Not yet recruiting
Mental health support for tropical disease care

This study brings mental health support directly to people affected by certain tropical diseases in Ghana. If you join, you'll get help to cope with the emotional and psychological challenges that often come with these conditions.

NCT05243654Recruiting· Phase 2
Metformin add-on for newly diagnosed leprosy treatment

This Phase 2 trial tests whether adding metformin to standard leprosy treatment (multidrug therapy, or MDT) helps people with multibacillary leprosy recover better and remain tolerable over 48 weeks. Participants also get monitored closely for side effects and safety issues.

Tangerang, Banten
NCT05597280Recruiting· Phase 3
Medicine given after exposure to prevent leprosy

This Phase 3 study tests whether taking preventive antibiotics after possible contact can stop leprosy from developing. If it works, it could protect people in affected communities from getting leprosy (and possibly related infections).

Moroni
NCT07538960Not yet recruiting
Study of cutaneous T-cell lymphoma at Hospital México, Costa Rica

This study looks at how cutaneous T-cell lymphoma (a rare type of skin lymphoma) is diagnosed and treated at a specific hospital in Costa Rica. It aims to understand the disease better and improve care for patients.

San José, Uruca

Hear when a new Leprosy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.